StonvexLoading…
StonvexStonvexStonvexCore line items from CIEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-06-04 | Q1 2026 2026-01-31 | Annual 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|---|
Revenue | $1.53B | $1.43B | $4.77B | $3.42B | $2.20B |
Operating Income | Not available | $189.41M | $197.53M | $187.04M | $113.50M |
Net Income | Not available | $150.28M | $123.34M | $103.85M | $53.54M |
EPS (Diluted) | $1.49 | $1.03 | $0.85 | $0.72 | $0.37 |
Total Assets | Not available | $5.89B | $5.86B | $5.75B | $5.66B |
Total Liabilities | Not available | $3.10B | $3.14B | $2.96B | $2.88B |
Cash & Equivalents | Not available | $1.12B | $1.09B | $1.06B | $949.77M |
Free Cash Flow OCF − CapEx | Not available | $153.76M | $665.29M | $339.64M | $205.05M |
Shares Outstanding | Not available | 141.45M | 141.02M | 141.34M | 141.69M |